Nothing Special   »   [go: up one dir, main page]

Latest News for: merck & co.

Edit

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma

Pharmiweb 27 Jan 2025
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA. This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S.
Edit

Migraine Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | ...

GetNews 24 Jan 2025
Key companies developing therapies for Migraine are - GlaxoSmithKline, Merck & Co., Inc., Pfizer, Bausch Health, Amgen, Abbvie Inc., AstraZeneca, Eli Lilly and Co., Teva Pharmaceuticals, Novartis AG, Eisai Co., Ltd., Abbott Laboratories, and others.
Edit

Malignant Pleural Mesothelioma Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight ...

GetNews 23 Jan 2025
Merck & Co ... Inhibrx, Nurix Therapeutics, Atara Biotherapeutics, TCR2 Therapeutics, RS Oncology, Sanofi, AstraZeneca, Merck & Co, Amphera BV, Polaris Pharmaceuticals, Sellas Life Sciences Group, ...
Edit

RFK Jr. releases financial disclosure

The Hill 23 Jan 2025
... company Merck. The prominent anti-vaccine proponent was co-counsel with the law firm Wisner Baum in suing Merck over allegations that Gardasil caused life-altering injury to young men and women.
Edit

Benign Prostatic Hyperplasia Treatment Market 2026: Segmentation Trends, Industry Size, Growth, Regional Opportunities and Forecast

GetNews 23 Jan 2025
In addition, more research is being conducted into the use of lasers, microwave energy, and other energy-based treatments for BPH ... (US), Abbott (US), Asahi Kasei Corporation (Japan), Merck & Co., Inc ... (Canada) ... (Israel), KARL STORZ SE & Co ... Company Name.
Edit

These NJ companies made Newsweek's list of most trustworthy in the U.S.

New Jersey Herald 22 Jan 2025
NJ 2025 State of the State. Phil Murphy on economy/innovation centers. New Jersey Gov. Phil Murphy gave his final State of the State address ... Food and beverage ... Princeton’s Bristol Myers Squibb ranked 28th, while Kenilworth-based Merck & Co ... Retail.
Edit

Polyvinyl Alcohol (PVOH) Market Report 2025 : New Trends, Opportunities And Global Forecast to 2028 ...

GetNews 21 Jan 2025
... (China), Sekisui Specialty Chemicals (Japan), Mitsubishi Chemical Corporation (Japan), Japan Vam and Poval Co Ltd (Japan), Merck Kgaa (Germany), Wacker Chemie AG (Germany), Denka Company Ltd (Japan).
Edit

Psoriasis Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | ...

GetNews 21 Jan 2025
... Biogen Idec, Boehringer Ingelheim, Celgene Corporation, Dr.Reddy`s Laboratories, Eli Lilly and Company, Forward Pharma, Johnson and Johnson (Janssen Biotech Inc.), Leo Pharma AS, Merck and Co.
Edit

Clostridium Difficile Infections Pipeline 2024: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight| Novartis ...

GetNews 17 Jan 2025
In September 2024, Crestone, Inc ... Clostridium difficile (C ... ADS024 ... Key companies developing therapies for Clostridium Difficile Infections are - Novartis AG, Astellas Pharma, Eli Lily & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co ... 1.
Edit

How RFK Jr. drove mistrust of a cancer prevention vaccine

Roll Call 16 Jan 2025
Kennedy is still listed as a co-counsel in cases that are part of multidistrict litigation filed against Merck ... Green, who advocates for vaccines and has worked at drug companies including Merck.
Edit

Restrictive Cardiomyopathy Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Array Biopharma, ...

GetNews 16 Jan 2025
Key Restrictive Cardiomyopathy Companies. Array Biopharma Inc., AstraZeneca, Sanofi Aventis U.S LLC, Hoffmann-La Roche Ltd., Merck & Co ... Camzyos™ ... 7MM ... Array Biopharma Inc., AstraZeneca, Sanofi Aventis U.S LLC, Hoffmann-La Roche Ltd., Merck & Co ... 1.
Edit

Short Bowel Syndrome Pipeline Trends 2024: Clinical Trials, Analysis of Clinical Trials, Therapies, MOA, ROA, ...

GetNews 16 Jan 2025
... are - VectivBio AG, 9 Meters Biopharma, Inc., Nutrinia Ltd., Takeda Pharmaceutical Company Limited, Merck KGaA, Zealand Pharma A/S, OxThera, Hanmi Pharm.Co., Ltd., and Pharmascience, Inc., and others.
Edit

Merck sees 2025 launch for simpler version of cancer drug Keytruda

Detroit news 14 Jan 2025
Merck & Co ... The latest version of Keytruda could eventually capture between 30% and 40% of the market for the original, Merck CEO Rob Davis said at the JPMorgan ...
Edit

Topical Drug Delivery Market Trends, Key Players Analysis, Regional Trends, Competitive Landscape, and Industry Potential ...

GetNews 14 Jan 2025
"The prominent players in the topical drug delivery market are Glenmark Pharmaceuticals Ltd ... (UK)" ... 234 – Tables. 50 – Figures ... (Mylan N.V.) (US), 3M (US), Merck & Co.Inc. ... (Israel), Bristol Myers Squibb (US), Lead Chemical Co., Ltd ... (India).
Edit

The CDC, Palantir and the AI-Healthcare Revolution

Scheerpost 14 Jan 2025
Vance and his rise to MAGA stardom, Thiel and Palantir co-founder Alex Karp met with the head of TIA at DARPA, John Poindexter, shortly after Palantir’s incorporation ... In March 2019, for example, co-authors Dr.

Article Search

tools

Most Viewed

×
×
×
×